BMI-1 Mouse anti-Human, Clone: AF27, eBioscience™

Mouse Monoclonal Antibody

Brand: Affymetrix eBioscience

Manufacturer Part Number: 14-9702-80

Code: NEW

Additional Details:
Additional Details: Weight: 0.09500kg

Disclaimers: For Research Use Only.

Product Code. 15517616


This item has been discontinued and is no longer available. View the product for possible alternatives or contact our Product Support team on 01509 555888 for assistance

Description and Specification


Antigen BMI-1
Applications Immunocytochemistry
Applications Immunohistochemistry (Frozen)
Applications Immunoprecipitation
Applications Microscopy
Clone AF27
Concentration 0.5mg/mL
Conjugate Unlabeled
Format Purified
Formulation aqueous buffer, 0.09% sodium azide, may contain carrier protein/stabilizer
Host Species Murine
Isotype IgG2a
Quantity 25μg
Regulatory Status RUO
Storage Requirements Store at 2-8°C.
Primary or Secondary Primary
Monoclonal or Polyclonal Monoclonal
Target Species Human

The monoclonal antibody AF27 recognizes human BMI-1 (B cell-specific Moloney murine leukemia virus integration site 1), a member of the polycomb group (PcG) proteins responsible for repression of gene expression through recognition and modification of histone methylation and chromatin structure. BMI-1 contains a ring finger domain, a helix-turn-helix domain necessary for inducing telomerase activity and is a member of the polycomb repressive complex 1 (PRC1). BMI-1 localizes to the nucleus and plays an important role in self-renewal of normal as well as hematopoietic, embryonic, neural, and other stem cell populations through regulation of genes involved in proliferation such as Sox2 and KLF4. Decreased BMI-1 expression is associated with differentiation, while overexpression is frequently found in variety of cancers. BMI-1 has been shown to be essential for epithelial to mesenchymal transition (EMT) in head and neck and breast cancers and elevated BMI-1 expression correlates with poor prognosis in patients with neuroblastoma, glioma, non-Hodgkin B-cell lymphoma, oropharyngeal squamous cell cancer, non-small cell lung cancer, and primary and metastatic melanoma.